Citation Impact
Citing Papers
In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter
2010 StandoutNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Receptor for Advanced Glycation End Products Expression on T Cells Contributes to Antigen-Specific Cellular Expansion In Vivo
2007
RAGE: A journey from the complications of diabetes to disorders of the nervous system – striking a fine balance between injury and repair
2005
Oxidative stress and diabetic cardiovascular complications
2005
RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic Nephropathy
2003
Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.
1998
Apoptosis in the nervous system
2000 StandoutNature
Redox Regulation of NF-kappa B Activation
1997
Neurologic Complications of the Reactivation of Varicella–Zoster Virus
2000 Standout
Inflammation and metabolic disorders
2006 StandoutNature
FEEL-1 and FEEL-2 Are Endocytic Receptors for Advanced Glycation End Products
2003
Advanced glycation and endothelial functions: A link towards vascular complications in diabetes
2004
Advanced Glycation End Products-Induced Gene Expression of Scavenger Receptors in Cultured Human Monocyte-Derived Macrophages
2000
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
2000 StandoutNature
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
1999
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
2002 StandoutNature
A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40
1995
Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein
2004
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
2001
How hyperglycemia promotes atherosclerosis: molecular mechanisms
2002
X-linked IAP is a direct inhibitor of cell-death proteases
1997 StandoutNature
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
2002 StandoutNature
The RING Finger
1993
A Genomic and Functional Inventory of Deubiquitinating Enzymes
2005 Standout
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes
2005
Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products
1997
High Sensitivity C-reactive Protein: An Emerging Role in Cardiovascular Risk Assessment
2002
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
1998
Diabetic Retinopathy
2012 Standout
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Life in extreme environments
2001 StandoutNature
The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
1996
Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.
1997
Neurodegeneration and Inflammation
2008
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein
1997
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
1995
Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin
1998
Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
2009
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress
1997
RAGE: A New Target for the Prevention and Treatment of the Vascular and Inflammatory Complications of Diabetes
2000
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
Modulation of phagosome biogenesis by Legionella pneumophila creates an organelle permissive for intracellular growth
1999
Atherosclerosis — An Inflammatory Disease
1999 Standout
Alzheimer's Disease
2010 Standout
Inflammation in atherosclerosis
2002 StandoutNature
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
2004
Blockade of Receptor for Advanced Glycation End-Products Restores Effective Wound Healing in Diabetic Mice
2001
Origin and physiological roles of inflammation
2008 StandoutNature
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Sp1-binding Elements in the Promoter of RAGE Are Essential for Amphoterin-mediated Gene Expression in Cultured Neuroblastoma Cells
1998
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Atherogenesis and Advanced Glycation: Promotion, Progression, and Preventiona
1997
Atherosclerosis
2000 StandoutNature
Elastin is an essential determinant of arterial morphogenesis
1998 StandoutNature
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways
1996 Standout
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes?the EURODIAB Prospective Complications Study
2005
Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation
2006
Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways
1999
Universal control mechanism regulating onset of M-phase
1990 StandoutNatureNobel
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
RAGE Mediates a Novel Proinflammatory Axis
1999 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Checkpoints: Controls That Ensure the Order of Cell Cycle Events
1989 StandoutScienceNobel
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
1999 StandoutScience
Blockade of Late Stages of Autoimmune Diabetes by Inhibition of the Receptor for Advanced Glycation End Products
2004
The Free Radical Theory of Aging Matures
1998 Standout
Advanced Glycation End Products
2006 Standout
Identification of Legionella pneumophila genes required for growth within and killing of human macrophages
1993
Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis
2004
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
1998 Standout
The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc
1996 StandoutScience
Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus.
1996
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
2003
The Pathobiology of Diabetic Complications
2005 Standout
Molecular Therapies for Vascular Diseases
1996 Science
The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins
2003
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
2008
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
1991 StandoutScience
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE
2002
Oxidative Stress and Diabetic Complications
2010 Standout
S Phase of the Cell Cycle
1989 Science
Electrochemiluminescence (ECL)
2004 Standout
Soluble Vascular Cell Adhesion Molecule-1 as a Biohumoral Correlate of Atherosclerosis
1997
Oxidative Stress as a Regulator of Gene Expression in the Vasculature
1999
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
2001
A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection
1989
RAGE Control of Diabetic Nephropathy in a Mouse Model
2006
Activation of Receptor for Advanced Glycation End Products
1999
Mechanisms of Diabetic Complications
2013 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease
2003 StandoutNobel
Glucosamine-Induced Endoplasmic Reticulum Dysfunction Is Associated With Accelerated Atherosclerosis in a Hyperglycemic Mouse Model
2006
Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy
2002
Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products
2004
Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency
1998
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
1996 StandoutNature
Advanced Glycation End Product (AGE)–Mediated Induction of Tissue Factor in Cultured Endothelial Cells Is Dependent on RAGE
1997
Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells.
2000
Free Radicals in the Physiological Control of Cell Function
2002 Standout
High Levels of Dietary Advanced Glycation End Products Transform Low-Dersity Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients
2004
Acute Hyperglycemia Causes Intracellular Formation of CML and Activation of ras, p42/44 MAPK, and Nuclear Factor κB in PBMCs
2003
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
2001
Autophagy in Health and Disease: A Double-Edged Sword
2004 StandoutScience
Works of J X Chen being referenced
Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.
1995
Isolation and characterization of auxotrophic mutants of Legionella pneumophila that fail to multiply in human monocytes
1988
Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products
1990